Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">On The Wires<ul><li>One Horizon Group, Inc. (<strong>OHGI</strong>) announced that Microsoft (<strong>MSFT</strong>) published a feature on how One Horizon Group improves its time to market, shortens its sales-cycles and improves service security by combining their patented VoIP technology with the power of the Microsoft Azure cloud platform. </li><li>Medicure (<strong>MCUJF</strong>), a leading Canadian specialty pharmaceutical company, announced that its majority-owned subsidiary, Apicore Inc., has received final approval from the U.S. Food and Drug Administration for the Company's abbreviated new drug application for tetrabenazine tablets in the 12.5 mg and 25 mg strengths. The newly approved product is a generic equivalent of the branded product Xenazine sold in the United States by Valeant Pharmaceuticals (<strong>VRX</strong>).</li><li>Cardtronics (<strong>CATM</strong>) and The Bank of Nova Scotia (<strong>BNS</strong>) announced a long-term renewal of the companies' ABM branding relationship in Canada. The agreement provides Scotiabank customers with No-Fee cash access at more than 640 Scotiabank-branded ABMs located at 7-Eleven Canada stores across the country. This renewed agreement includes an additional 130 locations in British Columbia and Alberta that have been added to 7-Eleven Canada's footprint in recent months.</li><li>Merrimack Pharmaceuticals (<strong>MACK</strong>) announced the enrollment of its first patient in a Phase 1 study of MM-310 in solid tumors. MM-310 is an antibody-directed nanotherapeutic (ADN) that encapsulates a novel taxane and targets the EphA2 receptor, a protein which surveys suggest is overexpressed in 50-100% of many major tumor types, including prostate, ovarian, bladder, gastric, pancreatic and lung cancers. Merrimack expects to report data from part one of the study in 2018.</li></ul></td> </tr></table>"